Literature DB >> 14667211

Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity.

Lian Qian1, Yong Xu, Yutaka Hasegawa, Junken Aoki, Gordon B Mills, Glenn D Prestwich.   

Abstract

The metabolically stabilized LPA analogue, 1-oleoyl-2-O-methyl-rac-glycerophosphothioate (OMPT), is a potent agonist for the LPA(3) G-protein-coupled receptor. A new enantiospecific synthesis of both (2R)-OMPT and (2S)-OMPT is described. Calcium release assays in both LPA(3)-transfected insect Sf9 and rat hepatoma Rh7777 cells showed that (2S)-OMPT was 5- to 20-fold more active than (2R)-OMPT. Similar results were found for calcium release, MAPK and Akt activation, and IL-6 release in human OVCAR3 ovarian cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667211     DOI: 10.1021/jm034207p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools.

Authors:  Jaclyn Long; Peter Darroch; Kah Fei Wan; Kok Choi Kong; Nicholas Ktistakis; Nigel J Pyne; Susan Pyne
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

2.  Chemical synthesis and molecular recognition of phosphatase-resistant analogues of phosphatidylinositol-3-phosphate.

Authors:  Yong Xu; Stephanie A Lee; Tatiana G Kutateladze; Diego Sbrissa; Assia Shisheva; Glenn D Prestwich
Journal:  J Am Chem Soc       Date:  2006-01-25       Impact factor: 15.419

3.  Development of an LC-MS/MS assay to determine plasma pharmacokinetics of the radioprotectant octadecenyl thiophosphate (OTP) in monkeys.

Authors:  Hari Kosanam; Fei Ma; Hui He; Suma Ramagiri; Veeresa Gududuru; Gabor J Tigyi; Koen Van Rompay; Duane D Miller; Charles R Yates
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-07-18       Impact factor: 3.205

Review 4.  Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer.

Authors:  Glenn D Prestwich; Joanna Gajewiak; Honglu Zhang; Xiaoyu Xu; Guanghui Yang; Monica Serban
Journal:  Biochim Biophys Acta       Date:  2008-04-08

5.  Synthesis, pharmacology, and cell biology of sn-2-aminooxy analogues of lysophosphatidic acid.

Authors:  Joanna Gajewiak; Ryoko Tsukahara; Yuko Fujiwara; Gabor Tigyi; Glenn D Prestwich
Journal:  Org Lett       Date:  2008-02-20       Impact factor: 6.005

6.  Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

Authors:  Yutong Zhao; Peter V Usatyuk; Rhett Cummings; Bahman Saatian; Donghong He; Tonya Watkins; Andrew Morris; Ernst W M Spannhake; David N Brindley; Viswanathan Natarajan
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

Review 7.  Lysophospholipid interactions with protein targets.

Authors:  Abby L Parrill
Journal:  Biochim Biophys Acta       Date:  2008-05-02

8.  Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways.

Authors:  Christina H Stuelten; Rachel M Lee; Wolfgang Losert; Carole A Parent
Journal:  Cell Signal       Date:  2018-01-11       Impact factor: 4.315

9.  Cost-effective and Large-scale synthesis of 16:0 Lysophosphatidic Acid.

Authors:  James E East; Timothy L Macdonald
Journal:  Synth Commun       Date:  2012-08-20       Impact factor: 2.007

10.  Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA.

Authors:  Guowei Jiang; Yong Xu; Yuko Fujiwara; Tamotsu Tsukahara; Ryoko Tsukahara; Joanna Gajewiak; Gabor Tigyi; Glenn D Prestwich
Journal:  ChemMedChem       Date:  2007-05       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.